ENDRA Life Sciences
NDRA
8 hedge funds and large institutions have $153K invested in ENDRA Life Sciences in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
60% more funds holding
Funds holding: 5 → 8 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
45% less capital invested
Capital invested by funds: $278K → $153K (-$125K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$53K |
| 2 |
Jane Street
New York
|
+$41.2K |
| 3 |
VF
Virtu Financial
New York
|
+$39.2K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$11.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$6.84K |
| 2 |
VNA
Valley National Advisers
Bethlehem,
Pennsylvania
|
-$1K |
| 3 |
BlackRock
New York
|
-$218 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $31.5K | +$1.96K | +1 | +3% |
|
|
TSS
2
Two Sigma Securities
New York
| $27.8K | +$53K | +27 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $23.1K | – | – | – |
|
|
4
Jane Street
New York
| $20.9K | +$41.2K | +21 | New |
|
|
VF
5
Virtu Financial
New York
| $20K | +$39.2K | +20 | New |
|
|
NA
6
NewEdge Advisors
New Orleans,
Louisiana
| $18K | – | – | – |
|
|
XT
7
XTX Topco
George Town,
Cayman Islands
| $6.24K | +$11.8K | +6 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $5.02K | +$5.88K | +3 | +150% |
|
9
Morgan Stanley
New York
| $193 | – | – | – |
|
10
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $191 | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $81 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $38 | – | – | – |
|
13
Fidelity Investments
Boston,
Massachusetts
| $9 | – | – | – |
|
|
14
JP Morgan Chase
New York
| – | -$6.84K | -2 | Closed |
|
|
15
BlackRock
New York
| – | -$218 | – | – |
|
|
VNA
16
Valley National Advisers
Bethlehem,
Pennsylvania
| – | -$1K | – | – |
|
NDRA Hedge Fund Activity: Q1 2024 in Review
8 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2024, worth a combined $153K — down 45% from $278K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NDRA positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $53K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $6.84K sold.
- 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2024, up from 5 in Q4 2023.
- Funds reported $153K of ENDRA Life Sciences stock for Q1 2024, down 45% quarter-over-quarter.
- 4 funds opened new ENDRA Life Sciences positions in Q1 2024 and 1 closed out, a net change of +3 holders.
- The largest ENDRA Life Sciences buyer in Q1 2024 was Two Sigma Securities, an estimated $53K added.
- The largest ENDRA Life Sciences seller in Q1 2024 was JP Morgan Chase, an estimated $6.84K sold.
Based on aggregated 13F filings for Q1 2024.